Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris

PHASE3CompletedINTERVENTIONAL

Enrollment

219

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Psoriasis Vulgaris

Interventions

DRUG

LEO 90100 Aerosol Foam

Calcipotriol 50 mcg/g (as hydrate) and betamethasone 0.5 mg/g (as dipropionate) Aerosol Foam 60 g per can, applied once daily for one week

DRUG

Daivobet® gel

Calcipotriol 50 mcg/g (as hydrate) and betamethasone 0.5 mg/g (as dipropionate) Gel 60 g per bottle, applied once daily for one week.

Trial Locations (1)

K.Papp Clinical Research Inc., Waterloo